Evidence map›Paper›PMID 32855846›Full record

ReviewTranslational vision science & technology2020

A Review of Deep Learning for Screening, Diagnosis, and Detection of Glaucoma Progression.

Atalie C Thompson, Alessandro A Jammal, Felipe A Medeiros

Abstract readReview
In one paragraph

Review in Translational vision science & technology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 75 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
75citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

75 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Artificial Intelligence in Glaucoma Detection and Progression.Advances in ophthalmology and optometry · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

15 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Atalie C ThompsonVision, Imaging and Performance Laboratory (VIP), Duke Eye Center, Duke University, Durham, NC, USA.
Alessandro A JammalVision, Imaging and Performance Laboratory (VIP), Duke Eye Center, Duke University, Durham, NC, USA.
Felipe A MedeirosVision, Imaging and Performance Laboratory (VIP), Duke Eye Center, Duke University, Durham, NC, USA.

Funding

The BCI (Brain Computer Interface) Glaucoma Study: Objective Home-Based Detection of Progressive Visual Function Loss in GlaucomaR01EY029885 · NEI · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI ASRANI, SANJAY, MEDEIROS, FELIPE · 2019 to 2022
$2.2M
Deep learning to quantify glaucomatous damage on fundus photographs for teleophthalmologyK23EY030897 · NEI · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI THOMPSON, ATALIE C · 2020 to 2024
$968k
NEI NIH HHS K23 EY030897NEI NIH HHS R01 EY029885
6 · The paper itself

Abstract

Because of recent advances in computing technology and the availability of large datasets, deep learning has risen to the forefront of artificial intelligence, with performances that often equal, or sometimes even exceed, those of human subjects on a variety of tasks, especially those related to image classification and pattern recognition. As one of the medical fields that is highly dependent on ancillary imaging tests, ophthalmology has been in a prime position to witness the application of deep learning algorithms that can help analyze the vast amount of data coming from those tests. In particular, glaucoma stands as one of the conditions where application of deep learning algorithms could potentially lead to better use of the vast amount of information coming from structural and functional tests evaluating the optic nerve and macula. The purpose of this article is to critically review recent applications of deep learning models in glaucoma, discussing their advantages but also focusing on the challenges inherent to the development of such models for screening, diagnosis and detection of progression. After a brief general overview of deep learning and how it compares to traditional machine learning classifiers, we discuss issues related to the training and validation of deep learning models and how they specifically apply to glaucoma. We then discuss specific scenarios where deep learning has been proposed for use in glaucoma, such as screening with fundus photography, and diagnosis and detection of glaucoma progression with optical coherence tomography and standard automated perimetry. Translational Relevance: Deep learning algorithms have the potential to significantly improve diagnostic capabilities in glaucoma, but their application in clinical practice requires careful validation, with consideration of the target population, the reference standards used to build the models, and potential sources of bias.

Indexed as

Deep LearningGlaucomaArtificial IntelligenceDiagnostic Techniques, OphthalmologicalHumansVisual Field Testsdeep learningglaucomaoptical coherence tomographyvisual fields

Identifiers

PMID32855846
PMCPMC7424906

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.